外用薬の市場規模、シェア、成長分析：投与経路別、タイプ別、最終用途別、地域別 - 産業予測 2025年～2032年

外用薬市場規模は2023年に1,905億米ドルと評価され、2024年の2,019億3,000万米ドルから2032年には3,218億5,000万米ドルに成長し、予測期間中（2025～2032年）のCAGRは6.0%で推移する見通しです。

外用薬市場は、スキンケアに対する意識の高まりと、様々な皮膚科疾患に対する局所治療の必要性に後押しされ、大きな成長を遂げています。消費者は、にきび、湿疹、乾癬、老化兆候などの問題に対する解決策を積極的に求めており、標的を絞った治療効果により、鎮痛クリームや経皮パッチの需要を牽引しています。ドラッグ製剤とデリバリー方法の革新が、製薬会社に多様な医療・美容ニーズに応える新しい外用製品の開発を促しています。さらに、スキンケアにおける天然成分やオーガニック成分への嗜好の高まりは、安全性と有効性に強く焦点を当てながら、市場の展望をさらに高めています。全体として、世界の外用医薬品市場は、研究開発努力によって新たな治療法が生み出され、消費者が肌の健康とウェルネスをますます優先するようになるにつれて、継続的な拡大が見込まれています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

外用薬市場規模：投与経路別& CAGR（2025-2032）

• 市場概要
• 皮膚
• 眼科
• 直腸
• 膣
• 鼻腔

外用薬市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 半固体
• 経皮

外用薬市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• クリニック
• 在宅設定

外用薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Glenmark Pharmaceuticals Ltd.（India）
• Johnson & Johnson Private Limited（USA）
• GlaxoSmithKline PLC（UK）
• Bausch Health Companies Inc.（Canada）
• Cipla Ltd.（India）
• Bayer AG（Germany）
• 3M（USA）
• Merck & Co., Inc.（USA）
• Crescita Therapeutics Inc.（Canada）
• Novartis International AG（Switzerland）
• Taro Pharmaceutical Industries Ltd.（Israel）
• Valeant Pharmaceuticals International Inc.（Canada）
• Encore Dermatology Inc.（USA）
• Medpharm Group Limited（UK）
• SkinVisible Pharmaceuticals Inc.（USA）
• Hisamitsu Pharmaceutical Co., Inc.（Japan）
• Pfizer Inc.（USA）
• Sanofi（France）
• Teva Pharmaceutical Industries Ltd.（Israel）

結論と推奨事項

Topical Drugs Market size was valued at USD 190.5 billion in 2023 and is poised to grow from USD 201.93 billion in 2024 to USD 321.85 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The topical drug market is experiencing significant growth, fueled by an increasing awareness of skincare and the need for localized treatments for various dermatological conditions. Consumers are actively seeking solutions for issues such as acne, eczema, psoriasis, and aging signs, driving demand for pain relief creams and transdermal patches due to their targeted therapeutic benefits. Innovation in drug formulations and delivery methods is prompting pharmaceutical companies to develop new topical products that cater to diverse medical and cosmetic needs. Additionally, the rising preference for natural and organic ingredients in skincare is further enhancing the market landscape, with a strong focus on safety and effectiveness. Overall, the global topical drug market is poised for continued expansion as R&D efforts yield new treatments and consumers increasingly prioritize skin health and wellness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Topical Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Topical Drugs Market Segments Analysis

Global Topical Drugs Market is segmented by Route of Administration, Type, End Use and region. Based on Route of Administration, the market is segmented into Dermal, Ophthalmic, Rectal, Vaginal and Nasal. Based on Type, the market is segmented into Semi-solid and Transdermal. Based on End Use, the market is segmented into Hospitals, Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Topical Drugs Market

A significant factor propelling the growth of the topical drugs market is the aging population. As the global demographic continues to age, there is an increasing need for skin care and dermatological treatments that address age-related skin concerns. Furthermore, the rising awareness regarding skin health, combined with a desire for a youthful appearance, is leading consumers to seek topical solutions, thereby driving market expansion. This trend reflects a heightened interest in maintaining skin vitality and combating visible signs of aging, which ultimately supports the growth of the topical drugs market and highlights the importance of innovative solutions in this sector.

Restraints in the Topical Drugs Market

The process of obtaining approval for topical medications often involves lengthy and costly procedures, necessitating extensive clinical trials and rigorous safety evaluations. Such regulatory requirements can significantly slow down the development of new products and hinder their entry into the market. As a result, pharmaceutical companies face substantial challenges in delivering innovative topical drugs, given the financial and time investments required to navigate these stringent approval processes. This situation represents a considerable restraint for the topical drugs market, as these barriers can limit the availability of new treatments, impacting both businesses and consumers seeking effective solutions.

Market Trends of the Topical Drugs Market

The Topical Drugs market is poised for significant growth, driven by the rise of telemedicine and e-pharmacies, which have revolutionized patient access to dermatological care. As healthcare shifts towards digital solutions, consumers increasingly favor the convenience and immediacy of receiving consultations online, leading to a surge in prescriptions for topical treatments. The demand for contactless healthcare solutions, alongside a growing inclination to purchase medications via digital channels, underpins this trend. As e-pharmacy platforms evolve and telehealth services expand, the market for topical drugs is expected to prosper, reflecting broader changes in consumer habits and healthcare delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Topical Drugs Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Dermal
• Ophthalmic
• Rectal
• Vaginal
• Nasal

Global Topical Drugs Market Size by Type & CAGR (2025-2032)

• Market Overview
• Semi-solid
• Transdermal

Global Topical Drugs Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Home Care Settings

Global Topical Drugs Market Size & CAGR (2025-2032)

• North America (Route of Administration, Type, End Use)
  • US
  • Canada
• Europe (Route of Administration, Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Route of Administration, Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Route of Administration, Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Route of Administration, Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Glenmark Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Private Limited (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crescita Therapeutics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taro Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeant Pharmaceuticals International Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Encore Dermatology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpharm Group Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SkinVisible Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations